Tuberculosis nucleic acids, polypeptides and immunogenic compositions
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-039/04
A61K-049/00
A61K-039/00
출원번호
UP-0291616
(2005-11-30)
등록번호
US-7608277
(2009-11-10)
발명자
/ 주소
Roth, David
He, Huaping
출원인 / 주소
Gene Therapy Systems, Inc.
대리인 / 주소
Knobbe, Martens, Olson & Bear LLP
인용정보
피인용 횟수 :
0인용 특허 :
10
초록▼
The present invention provides transcriptionally active Mtb polynucleotides, recombinant Mtb peptides and polypeptides, and immunogenic Mtb antigens. Immunogenic compositions are also provided that may be useful as recombinant, subunit and DNA vaccines. In addition, the invention provides diagnostic
The present invention provides transcriptionally active Mtb polynucleotides, recombinant Mtb peptides and polypeptides, and immunogenic Mtb antigens. Immunogenic compositions are also provided that may be useful as recombinant, subunit and DNA vaccines. In addition, the invention provides diagnostic kits for Mtb.
대표청구항▼
What is claimed is: 1. An isolated Mtb peptide or polypeptide selected from the group consisting of SEQ ID NOS: 68, 70, 73, 74, 75, 77, 78, 83, 122, 123, 124, 125, 126, 128, 129, 130, 132, and 133, or an immunogenic fragment thereof. 2. The peptide or polypeptide of claim 1, wherein said peptide
What is claimed is: 1. An isolated Mtb peptide or polypeptide selected from the group consisting of SEQ ID NOS: 68, 70, 73, 74, 75, 77, 78, 83, 122, 123, 124, 125, 126, 128, 129, 130, 132, and 133, or an immunogenic fragment thereof. 2. The peptide or polypeptide of claim 1, wherein said peptide or polypeptide reacts with polyclonal antibodies directed to Mtb bacteria. 3. The peptide or polypeptide of claim 1, wherein said peptide or polypeptide is detected by either ELISA or Western blotting. 4. A recombinant Mtb peptide or polypeptide, wherein the amino terminus of said peptide or polypeptide comprises a HA tag or a His tag, and the carboxy terminus of said peptide or polypeptide is selected from the group consisting of: SEQ ID NOS: 68, 70, 73, 74, 75, 77, 78, 83, 122 123, 124, 125, 126, 128, 129, 130, 132, and 133. 5. A recombinant Mtb peptide or polypeptide, wherein the carboxy terminus of said peptide or polypeptide comprises a HA tag or a His tag, and the amino terminus of said peptide or polypeptide is selected from the group consisting of SEQ ID NOS: 68, 70, 73, 74, 75, 77, 78, 83, 122, 123, 124, 125, 126, 128, 129, 130, 132 and 133. 6. A composition comprising at least one isolated Mtb peptide or polypeptide selected from the group consisting of: SEQ ID NOS: 68, 70, 73, 74, 75, 77, 78, 83, 122, 123, 124, 125, 126, 128, 129, 130, 132, and 133, or an immunogenic fragment thereof, and a pharmaceuticallv acceptable carrier. 7. The composition of claim 6, further comprising an adjuvant. 8. A method of generating an immune response in a mammalian host against Mtb comprising administering to said mammalian host at least one peptide, polypeptide or immunogenic fragment thereof of claim 1 or any combination thereof, whereby said immune response against Mtb is generated. 9. The method according to claim 8, further comprising administering an adjuvant to said mammalian host. 10. A kit comprising: a) at least one peptide or polypeptide of claim 1; and b) an adjuvant. 11. The kit of claim 10 comprising at least two of said polypeptides or peptides. 12. The composition of claim 6, wherein said peptide or polypeptide or immunogenic fragment thereof is a native protein. 13. The composition of claim 6, wherein said peptide or polypeptide or immunogenic fragment thereof is conjugated to a molecule. 14. The composition of claim 13, wherein said molecule is a polysaccharide. 15. The composition of claim 6, wherein said peptide or polypeptide is part of a complex of multiple polypeptide chains. 16. The composition of claim 6, wherein said peptide or polypeptide reacts with polyclonal antibodies directed to Mtb bacteria. 17. The composition of claim 6, wherein said Mtb peptide or polypeptide further comprises a tag, wherein said tag is at the amino terminus or carboxy terminus of said Mtb polypeptide. 18. The composition of claim 17, wherein said tag is a His tag or an HA tag. 19. A kit comprising: a) at least one composition of claim 6; and b) an adjuvant. 20. The kit of claim 19, comprising at least two of said immunogenic compositions. 21. A method of generating an immune response in a mammalian host against Mtb comprising administering to said mammalian host at least one composition of claim 6, or combination thereof, whereby said immune response against Mtb is generated.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (10)
Steven G. Reed ; Yasir A. W. Skeiky ; Davin C. Dillon, Compositions and methods for the prevention and treatment of M. tuberculosis infection.
Steven G. Reed ; Yasir A. W. Skeiky ; Davin C. Dillon ; Antonio Campos-Neto ; Raymond Houghton ; Thomas S. Vedvick ; Daniel R. Twardzik ; Michael J. Lodes ; Ronald C. Hendrickson, Compounds and methods for diagnosis of tuberculosis.
Reed, Steven G.; Skeiky, Yasir A. W.; Dillon, Davin C.; Campos-Neto, Antonio; Houghton, Raymond; Vedvick, Thomas S.; Twardzik, Daniel R.; Lodes, Michael J.; Hendrickson, Ronald C., Compounds and methods for immunotherapy and diagnosis of tuberculosis.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.